Viridian Therapeutics, Inc.

Q2 2022 13F Holders

Symbol
VRDN
CUSIP
92790C104
Type
Equity
Class
COM
Num filings
92
Total reported value, excl. options
$328 M
Manager Report Date Value ($000) Shares Option Type